230 related articles for article (PubMed ID: 12618649)
1. [Clinical presentation of immune mediated cerebellar ataxia].
Honnorat J; Trouillas P
Rev Neurol (Paris); 2003 Jan; 159(1):11-22. PubMed ID: 12618649
[TBL] [Abstract][Full Text] [Related]
2. Clinical presentation of immune-mediated cerebellar ataxia.
Demarquay G; Honnorat J
Rev Neurol (Paris); 2011 May; 167(5):408-17. PubMed ID: 21055784
[TBL] [Abstract][Full Text] [Related]
3. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
4. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
[TBL] [Abstract][Full Text] [Related]
5. [Autoantibodies associated with autoimmune-mediated cerebellar ataxia].
Mitoma H; Nanri K
Brain Nerve; 2013 Apr; 65(4):355-64. PubMed ID: 23568983
[TBL] [Abstract][Full Text] [Related]
6. [Paraneoplastic cerebellar degeneration].
Sakai K
Brain Nerve; 2010 Apr; 62(4):357-64. PubMed ID: 20420175
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic cerebellar ataxia associated with anti-Hu antibodies and benign ganglioneuroma.
Fancellu R; Corsini E; Bernardi G; Buzzo P; Ferrari ML; Lamantea E; Garaventa A; Truini M; Salvarani S
Funct Neurol; 2014; 29(4):277-80. PubMed ID: 25764259
[TBL] [Abstract][Full Text] [Related]
8. [Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma].
Huober J; Niedermaier N; Drlicek M; Kaufmann M; Hacke W; Bastert G
Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):214-6. PubMed ID: 8682288
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor.
Sillevis Smitt P; Kinoshita A; De Leeuw B; Moll W; Coesmans M; Jaarsma D; Henzen-Logmans S; Vecht C; De Zeeuw C; Sekiyama N; Nakanishi S; Shigemoto R
N Engl J Med; 2000 Jan; 342(1):21-7. PubMed ID: 10620645
[No Abstract] [Full Text] [Related]
10. New autoantibody mediated disorders of the central nervous system.
Lang B; Dale RC; Vincent A
Curr Opin Neurol; 2003 Jun; 16(3):351-7. PubMed ID: 12858073
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to cerebellar nerve fibres in two patients with paraneoplastic cerebellar ataxia.
Balegno S; Ceroni M; Corato M; Franciotta D; Giometto B; Marinu-Aktipu K; Nano R
Anticancer Res; 2005; 25(5):3211-4. PubMed ID: 16101129
[TBL] [Abstract][Full Text] [Related]
12. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
[TBL] [Abstract][Full Text] [Related]
13. Cerebellar ataxia as a possible organ-specific autoimmune disease.
Hadjivassiliou M; Boscolo S; Tongiorgi E; Grünewald RA; Sharrack B; Sanders DS; Woodroofe N; Davies-Jones GA
Mov Disord; 2008 Jul; 23(10):1370-7. PubMed ID: 18546342
[TBL] [Abstract][Full Text] [Related]
14. Immune-mediated acquired ataxias.
Hadjivassiliou M
Handb Clin Neurol; 2012; 103():189-99. PubMed ID: 21827889
[TBL] [Abstract][Full Text] [Related]
15. Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.
Mitoma H; Manto M; Hampe CS
Curr Neuropharmacol; 2019; 17(1):33-58. PubMed ID: 30221603
[TBL] [Abstract][Full Text] [Related]
16. [Anti-neuronal antibodies and central nervous system diseases: contribution to diagnosis and pathophysiology].
Antoine JC; Honnorat J
Rev Neurol (Paris); 2000 Jan; 156(1):23-33. PubMed ID: 10693255
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
18. Advances in Therapies of Cerebellar Disorders: Immune-mediated Ataxias.
Hadjivassiliou M
CNS Neurol Disord Drug Targets; 2019; 18(6):423-431. PubMed ID: 29268693
[TBL] [Abstract][Full Text] [Related]
19. Proteasome antibodies in paraneoplastic cerebellar degeneration.
Storstein A; Knudsen A; Vedeler CA
J Neuroimmunol; 2005 Aug; 165(1-2):172-8. PubMed ID: 15964637
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody-mediated disorders of the central nervous system.
Irani S; Lang B
Autoimmunity; 2008 Feb; 41(1):55-65. PubMed ID: 18176865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
